Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Olema Pharmaceuticals, Inc. (OLMA)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
29 Feb 2024
Harmon Cyrus
Director
Olema Pharmaceuticals, Inc.
(OLMA)
846,383
-2%
25,000
$12.41
$310,309.00
SELL
31 Jan 2024
Harmon Cyrus
Director
Olema Pharmaceuticals, Inc.
(OLMA)
871,283
-3%
30,000
$12.79
$383,550.00
SELL
29 Dec 2023
Harmon Cyrus
Director
Olema Pharmaceuticals, Inc.
(OLMA)
903,783
-2%
25,000
$13.38
$334,500.00
SELL
8 Nov 2023
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
561,270
-0%
200
$17.61
$3,522.00
SELL
1 Nov 2023
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
561,470
-1%
10,541
$15.26
$160,805.78
SELL
31 Oct 2023
Harmon Cyrus
Director
Olema Pharmaceuticals, Inc.
(OLMA)
943,714
-3%
30,000
$12.65
$379,450.00
SELL
19 Sep 2023
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
572,011
-3%
20,000
$12.67
$253,400.00
BUY
12 Sep 2023
BVF PARTNERS L P/IL
Director, 10% Owner
Olema Pharmaceuticals, Inc.
(OLMA)
4,688,954
+47%
1,505,932
$9.84
$14,818,371.00
BUY
12 Sep 2023
Graham G. Walmsley
Director
Olema Pharmaceuticals, Inc.
(OLMA)
1,700,000
+60%
640,000
$10.74
$6,871,280.00
SELL
31 Aug 2023
Harmon Cyrus
Director
Olema Pharmaceuticals, Inc.
(OLMA)
998,714
-2%
25,000
$10.26
$256,600.00
SELL
16 Aug 2023
Harmon Cyrus
Director
Olema Pharmaceuticals, Inc.
(OLMA)
1,023,714
-1%
15,000
$10.14
$152,100.00
SELL
16 Aug 2023
Harmon Cyrus
Director
Olema Pharmaceuticals, Inc.
(OLMA)
1,023,714
-1%
15,000
$10.14
$152,100.00
SELL
8 Jun 2023
Harmon Cyrus
Director
Olema Pharmaceuticals, Inc.
(OLMA)
1,038,714
-0%
10,000
$6.30
$63,000.00
SELL
5 Jun 2023
Harmon Cyrus
Director
Olema Pharmaceuticals, Inc.
(OLMA)
1,048,714
-0%
10,000
$6.17
$61,700.00
BUY
10 Jun 2022
BVF PARTNERS L P/IL
Director, 10% Owner
Olema Pharmaceuticals, Inc.
(OLMA)
3,913,676
+5%
200,000
$4.03
$806,900.00
SELL
10 Mar 2022
Horn Kinney
CHIEF BUSINESS OFFICER, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
2,458
-68%
5,253
$4.75
$24,951.75
SELL
10 Jan 2022
Horn Kinney
CHIEF BUSINESS OFFICER, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
2,458
-68%
5,251
$6.85
$35,969.35
SELL
10 Dec 2021
Horn Kinney
CHIEF BUSINESS OFFICER, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
2,458
-68%
5,251
$10.39
$54,557.89
SELL
10 Dec 2021
Myles David C.
CHIEF DEVELOPMENT OFFICER, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
582,901
-1%
10,000
$10.30
$103,000.00
BUY
30 Nov 2021
BVF PARTNERS L P/IL
Director, 10% Owner
Olema Pharmaceuticals, Inc.
(OLMA)
3,755,093
+24%
739,675
$9.39
$6,945,770.00
SELL
29 Nov 2021
Harmon Cyrus
CHIEF TECHNOLOGY OFFICER, Director, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
1,051,146
-0%
400
$24.76
$9,904.00
SELL
10 Nov 2021
Horn Kinney
CHIEF BUSINESS OFFICER, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
1,790
-93%
27,668
$26.88
$743,715.80
SELL
19 Oct 2021
Harmon Cyrus
CHIEF TECHNOLOGY OFFICER, Director, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
1,056,101
-1%
12,000
$27.98
$335,794.25
SELL
14 Oct 2021
Bohen Sean
PRESIDENT AND CEO, Director, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
52,865
-8%
5,000
$30.47
$152,363.25
SELL
11 Oct 2021
Horn Kinney
CHIEF BUSINESS OFFICER, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
4,936
-51%
5,251
$27.90
$146,510.10
SELL
27 Sep 2021
Bohen Sean
PRESIDENT AND CEO, Director, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
52,514
-2%
1,085
$30.07
$32,625.95
SELL
20 Sep 2021
Harmon Cyrus
CHIEF TECHNOLOGY OFFICER, Director, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
1,063,546
-1%
12,000
$26.30
$315,600.00
SELL
10 Sep 2021
Horn Kinney
CHIEF BUSINESS OFFICER, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
1,790
-74%
5,251
$29.38
$154,274.38
SELL
7 Sep 2021
Bohen Sean
PRESIDENT AND CEO, Director, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
52,514
-5%
3,044
$30.01
$91,353.04
SELL
1 Sep 2021
Bohen Sean
PRESIDENT AND CEO, Director, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
54,274
-1%
871
$30.05
$26,173.55
SELL
19 Aug 2021
Harmon Cyrus
CHIEF TECHNOLOGY OFFICER, Director, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
1,075,546
-1%
12,000
$24.97
$299,640.00
SELL
10 Aug 2021
Horn Kinney
CHIEF BUSINESS OFFICER, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
1,850
-73%
5,251
$25.71
$134,978.90
SELL
20 Jul 2021
Harmon Cyrus
CHIEF TECHNOLOGY OFFICER, Director, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
1,087,546
-1%
12,000
$25.10
$301,258.38
SELL
12 Jul 2021
Horn Kinney
CHIEF BUSINESS OFFICER, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
3,182
-62%
5,251
$26.51
$139,191.47
SELL
18 Jun 2021
Harmon Cyrus
CHIEF TECHNOLOGY OFFICER, Director, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
1,102,136
-1%
12,000
$24.80
$297,625.50
SELL
10 Jun 2021
Horn Kinney
CHIEF BUSINESS OFFICER, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
6,741
-43%
5,251
$29.72
$156,070.80
SELL
18 May 2021
Horn Kinney
CHIEF BUSINESS OFFICER, Officer
Olema Pharmaceuticals, Inc.
(OLMA)
10,411
-84%
57,763
$24.15
$1,394,769.20
BUY
23 Nov 2020
Cormorant Asset Management, LP
Former 10% Owner
Olema Pharmaceuticals, Inc.
(OLMA)
3,270,544
+14%
425,000
$19.00
$8,075,000.00
BUY
23 Nov 2020
Graham G. Walmsley
Director
Olema Pharmaceuticals, Inc.
(OLMA)
1,160,000
+100%
1,160,000
$19.00
$22,040,000.00
BUY
18 Nov 2020
BVF PARTNERS L P/IL
Director, 10% Owner
Olema Pharmaceuticals, Inc.
(OLMA)
3,392,663
+50%
1,135,334
$19.00
$21,571,344.00
Home